F Mauvais-Jarvis
Overview
Explore the profile of F Mauvais-Jarvis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
857
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Basile G, Qadir M, Mauvais-Jarvis F, Vetere A, Shoba V, Modell A, et al.
Mol Metab
. 2022 Mar;
60:101477.
PMID: 35331962
Background: Stem cell therapies are finally coming of age as a viable alternative to pancreatic islet transplantation for the treatment of insulin-dependent diabetes. Several clinical trials using human embryonic stem...
2.
Choukem S, Sobngwi E, Garnier J, Letellier S, Mauvais-Jarvis F, Calvo F, et al.
Diabetes Metab
. 2015 Sep;
41(4):326-330.
PMID: 26337344
Aim: Previously, we described patients with ketosis-prone type 2 diabetes (KPD) and glucose-6-phosphate dehydrogenase (G6PD) deficiency, but no mutation of the G6PD gene. Our present study used two complementary approaches...
3.
Liu S, Kilic G, Meyers M, Navarro G, Wang Y, Oberholzer J, et al.
Diabetologia
. 2012 Nov;
56(2):370-81.
PMID: 23132340
Aims/hypothesis: Pancreatic islet transplantation (PIT) offers a physiological treatment for type 1 diabetes, but the failure of islet engraftment hinders its application. The female hormone 17β-oestradiol (E2) favours islet survival...
4.
Louet J, Smith S, Gautier J, Molokhia M, Virally M, Kevorkian J, et al.
Diabetes Obes Metab
. 2007 Dec;
10(10):912-20.
PMID: 18093211
Ketosis-prone diabetes (KPD) is a phenotypically defined form of diabetes characterized by male predominance and severe insulin deficiency. Neurogenin3 (NGN3) is a proendocrine gene, which is essential for the fate...
5.
Gautier J, Mauvais-Jarvis F, Sobngwi E
Journ Annu Diabetol Hotel Dieu
. 2004 Jul;
:79-93.
PMID: 15259307
No abstract available.
6.
Postic C, Mauvais-Jarvis F, Girard J
Ann Endocrinol (Paris)
. 2004 May;
65(1):51-9.
PMID: 15122092
No abstract available.
7.
Boudou P, Sobngwi E, Mauvais-Jarvis F, Vexiau P, Gautier J
Eur J Endocrinol
. 2003 Oct;
149(5):421-4.
PMID: 14585088
Objective: We investigated the effect of an intensive training program on fasting leptin and adiponectin levels. Methods: Sixteen middle-aged men with type 2 diabetes were randomly assigned to either a...
8.
Mauvais-Jarvis F, Boudou P, Sobngwi E, Riveline J, Kevorkian J, Villette J, et al.
Diabetologia
. 2003 May;
46(5):728-9.
PMID: 12743700
No abstract available.
9.
Sobngwi E, Vexiau P, Levy V, Lepage V, Mauvais-Jarvis F, Leblanc H, et al.
Diabet Med
. 2002 Oct;
19(10):832-5.
PMID: 12358870
Aims: We aimed to characterize a cohort of 'atypical' diabetic patients of sub-Saharan African origin and to analyse possible determinants of long-term remission. Methods: Over 6 years, we studied the...
10.
Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya J, Gautier J
Diabetes Metab
. 2002 Apr;
28(1):5-12.
PMID: 11938022
Diabetes is increasing with ageing and changes in lifestyle in populations of African ancestry as described in the first part of this review. Apart from classical type 1 and Type...